Post-Operative Pain - Pipeline Review, H1 2018

Date: January 18, 2018
Pages: 218
Price:
US$ 2,000.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P05D43870BFEN
Leaflet:

Download PDF Leaflet

Post-Operative Pain - Pipeline Review, H1 2018
Post-Operative Pain - Pipeline Review, H1 2018

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H1 2018, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.

Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 1, 8, 18, 8, 1, 21, 3 and 3 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules, respectively.

Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)
REASONS TO BUY
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


NOTE: Out of security concerns Global Markets Direct requires using corporate email address.
Introduction
Post-Operative Pain - Overview
Post-Operative Pain - Therapeutics Development
Post-Operative Pain - Therapeutics Assessment
Post-Operative Pain - Companies Involved in Therapeutics Development
Post-Operative Pain - Drug Profiles
Post-Operative Pain - Dormant Projects
Post-Operative Pain - Discontinued Products
Post-Operative Pain - Product Development Milestones
Appendix

LIST OF TABLES

Number of Products under Development for Post-Operative Pain, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd.1), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd.2), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd.1), H1 2018
Products under Development by Companies, H1 2018 (Contd.2), H1 2018
Products under Development by Companies, H1 2018 (Contd.3), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Target, H1 2018 (Contd.1), H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018 (Contd.1), H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Post-Operative Pain - Pipeline by Abide Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H1 2018
Post-Operative Pain - Pipeline by Adynxx Inc, H1 2018
Post-Operative Pain - Pipeline by AngioChem Inc, H1 2018
Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H1 2018
Post-Operative Pain - Pipeline by Apsen Farmaceutica SA, H1 2018
Post-Operative Pain - Pipeline by Cadila Healthcare Ltd, H1 2018
Post-Operative Pain - Pipeline by Camurus AB, H1 2018
Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by Center Laboratories Inc, H1 2018
Post-Operative Pain - Pipeline by Colby Pharmaceutical Co, H1 2018
Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H1 2018
Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H1 2018
Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H1 2018
Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H1 2018
Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H1 2018
Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H1 2018
Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by Immupharma Plc, H1 2018
Post-Operative Pain - Pipeline by Innocoll AG, H1 2018
Post-Operative Pain - Pipeline by Insys Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by Ionis Pharmaceuticals Inc, H1 2018
Post-Operative Pain - Pipeline by iX Biopharma Ltd, H1 2018
Post-Operative Pain - Pipeline by Lipocure Ltd, H1 2018
Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H1 2018
Post-Operative Pain - Pipeline by Lumosa Therapeutics Co Ltd, H1 2018
Post-Operative Pain - Pipeline by Medtronic Plc, H1 2018
Post-Operative Pain - Pipeline by Mundipharma International Ltd, H1 2018
Post-Operative Pain - Pipeline by Neumentum Inc, H1 2018
Post-Operative Pain - Pipeline by Novartis AG, H1 2018
Post-Operative Pain - Pipeline by Ocular Therapeutix Inc, H1 2018
Post-Operative Pain - Pipeline by Orion Corporation, H1 2018
Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H1 2018
Post-Operative Pain - Pipeline by PainReform Ltd, H1 2018
Post-Operative Pain - Pipeline by Pharmaleads SA, H1 2018
Post-Operative Pain - Pipeline by PhytoHealth Corp, H1 2018
Post-Operative Pain - Pipeline by PixarBio Corp, H1 2018
Post-Operative Pain - Pipeline by RaQualia Pharma Inc, H1 2018
Post-Operative Pain - Pipeline by Recro Pharma Inc, H1 2018
Post-Operative Pain - Pipeline by Relmada Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H1 2018
Post-Operative Pain - Pipeline by Taiwan Liposome Company Ltd, H1 2018
Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H1 2018
Post-Operative Pain - Pipeline by Trevena Inc, H1 2018
Post-Operative Pain - Pipeline by Xigen SA, H1 2018
Post-Operative Pain - Dormant Projects, H1 2018
Post-Operative Pain - Dormant Projects, H1 2018 (Contd.1), H1 2018
Post-Operative Pain - Dormant Projects, H1 2018 (Contd.2), H1 2018
Post-Operative Pain - Dormant Projects, H1 2018 (Contd.3), H1 2018
Post-Operative Pain - Discontinued Products, H1 2018

LIST OF FIGURES

Number of Products under Development for Post-Operative Pain, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Top 10 Routes of Administration, H1 2018
Number of Products by Stage and Top 10 Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018

COMPANIES MENTIONED

Abide Therapeutics Inc
AcelRx Pharmaceuticals Inc
Adynxx Inc
AngioChem Inc
Aoxing Pharmaceutical Company Inc
Apsen Farmaceutica SA
Cadila Healthcare Ltd
Camurus AB
Cara Therapeutics Inc
Center Laboratories Inc
Colby Pharmaceutical Co
Cytogel Pharma LLC
Dompe Farmaceutici SpA
Eupraxia Pharmaceuticals Inc
EyeGate Pharmaceuticals Inc
Fujimoto Pharmaceutical Corp
GW Pharmaceuticals Plc
Heron Therapeutics Inc
Immupharma Plc
Innocoll AG
Insys Therapeutics Inc
Ionis Pharmaceuticals Inc
iX Biopharma Ltd
Lipocure Ltd
Liquidia Technologies Inc
Lumosa Therapeutics Co Ltd
Medtronic Plc
Mundipharma International Ltd
Neumentum Inc
Novartis AG
Ocular Therapeutix Inc
Orion Corporation
Pacira Pharmaceuticals Inc
PainReform Ltd
Pharmaleads SA
PhytoHealth Corp
PixarBio Corp
RaQualia Pharma Inc
Recro Pharma Inc
Relmada Therapeutics Inc
Serina Therapeutics Inc
SteadyMed Therapeutics Inc
Taiwan Liposome Company Ltd
Teikoku Pharma USA Inc
Trevena Inc
Xigen SA
Skip to top


Cancer Pain - Pipeline Review, H1 2018 US$ 2,000.00 Apr, 2018 · 119 pages
Osteoarthritis Pain - Pipeline Review, H1 2017 US$ 2,000.00 May, 2017 · 202 pages
Post-Operative Pain - Pipeline Review, H2 2018 US$ 2,000.00 Jul, 2018 · 232 pages

Ask Your Question

Post-Operative Pain - Pipeline Review, H1 2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: